| Details |
| Disease Name | Multiple Sclerosis, Relapsing-Remitting |
| Nocoding RNA Name | hsa-miR-26 |
| Expression Pattern | down-regulated |
| Species | Homo sapiens |
| Detection Methods | RT-PCR etc. |
| Target | POU2AF1 |
| Tissue | blood(Peripheral blood mononuclear cells) |
| Treatment | natalizumab |
| PubMed ID | 24598267 |
| Year | 2014 |
| Detail Description | MiR-126 expression was significantly down-regulated in both the groups of natalizumab-treated patients.seven independent experiments resulted in significant down-regulation of miR-126 expression and consequently, significant up-regulation of POU2AF1 and Spi-B expression. |
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback
© All right reserved 2016